|
Symposium (Tentative Program)
|
|
|
Date : February 25 (Thursday) , 2010  Venue : Hotel Granvia Okayama
|
|
|
Opening Remarks by Kazuaki Mitsudo, M.D. |
|
|
|
|
|
10:00-12:05 |
|
|
Chairman: Yasuhiko Hayashi, M.D. |
|
|
|
|
|
Status of Vascular Disease World Wide |
|
|
Bruce Edward Murphy, M.D. (Arkansas Heart Hospital) |
|
|
Co-sponsored by Boston Scientific Japan K.K.
|
|
|
Increased Tissue Factor Expression after DES Implants
in Porcine Coronary Arteries May Contribute
to Late Stent Thrombosis |
|
|
Go Haraguchi, M.D. (Tokyo Medical and Dental University School of Medicine) |
|
|
Co-sponsored by Medtronic Japan co., Ltd.
|
|
|
Abbott Vascular DES Program Update: ABSORB and SPIRIT |
|
|
Shuzou Tanimoto, M.D. (Mitsui Memorial Hospital) |
|
|
Co-sponsored by Abbott Vascular Japan Co., Ltd.
|
|
|
Sirolimus Eluting Stent: Now and Future |
|
|
Peter J. Fitzgerald, M.D. (Stanford University) |
|
|
Co-sponsored by Johnson & Johnson K.K. Cordis Cardiology Japan
|
|
|
J-Cypher |
|
|
Takeshi Kimura, M.D. (Kyoto University Hosptal) |
|
|
|
|
|
12:05-12:35 Lunch Time (30 minutes) |
|
|
|
|
|
12:35-14:15 |
|
|
Chairman: Nobuo Shiode, M.D |
|
|
BioFreedom First In Man Progress Report : 4 Month Cohort Follow-Up |
|
|
Norio Tada, M.D. (Sendai Kousei Hospital) |
|
|
Co-sponsored by Biosensors Japan Co., Ltd.
|
|
|
OPTIMIZE Rationale |
|
|
Ricardo A. Costa , M.D. (Instituto Dante Pazzanese de Cardiologia) |
|
|
Co-sponsored by Medtronic Japan co., Ltd.
|
|
|
NOBORI clinical trial program update |
|
|
Masashi Iwabuchi, M.D. (Kokura Memorial Hospital) |
|
|
Co-sponsored by TERUMO Corporation
|
|
|
PEPCAD update |
|
|
Seiji Habara , M.D.
(Kurashiki Central Hospital) |
|
|
Co-sponsored by NIPRO Corporation
|
|
|
|
|
|
14:15-15:05 |
|
|
Chairman: Seiich Haruta, M.D |
|
|
Drug Eluting Balloon: My first experience |
|
|
Naoto Inoue, M.D. (Sendai Kousei Hospital) |
|
|
Co-sponsored by INVAtec Japan K.K.
|
|
|
Novel Pro-Healing SES; The Future Direction of Pro-Healing Approach |
|
|
Gaku Nakazawa, M.D. (Tokai University) |
|
|
Co-sponsored by OrbusNeich Medical K.K.
|
|
|
15:05-15:25 Coffee Break (20 minutes) |
|
|
|
|
|
15:25-16:40 |
|
|
Chairman: Seiich Haruta, M.D |
|
|
0.010-inch system for bifurcation lesion |
|
|
Yoritaka Otsuka, M.D. (National Cardiovascular Center) |
|
|
Co-sponsored by Kaneka Medix Corporation
|
|
|
Why is renal artery disease screening key
in coronary artery disease patients? |
|
|
Takehiro Yamashita, M.D. (Cardio-vascular Center Hokkaido Ohno Hospital) |
|
|
Co-sponsored by Johnson & Johnson k.k.
Cordis Endovascular Systems Japan
|
|
|
Application of ASAHI Corsair® in CTO-PCI |
|
|
Masahisa Yamane, M.D. (Sekishinkai Sayama Hospital) |
|
|
Co-sponsored by ASAHI INTECC J sales, INC
|
|
|
|
|
|
16:40-18:45 |
|
|
Chairman: Koichiro Iwasaki, M.D |
|
|
Coronary Angioscope stepping forward in DES era |
|
|
Toshiro Shinke, M.D. (Kobe University Graduate School of Medicine) |
|
|
Co-sponsored by Japan Lifeline Co.,Ltd
|
|
|
Fractional Flow Reserve `The FAME Study Two-Year Results` |
|
|
Takashi Akasaka, M.D.
(Wakayama Medical University) |
|
|
Co-sponsored by St. Jude Medical Japan Co.,Ltd.
|
|
|
Intracoronary OCT: Changing trends in diagnosis and therapeutics |
|
|
Takashi Akasaka, M.D.
(Wakayama Medical University) |
|
|
Co-sponsored by Goodman Co,. Ltd.
|
|
|
Lessons from PROSPECT and future |
|
|
Naoto Inoue, M.D. (Sendai Kousei Hospital) |
|
|
Co-sponsored by Volcano Japan Co,. Ltd.
|
|
|
Excimer Laser: Current Status of Coronary and Overview
of Peripheral and Lead Extraction |
|
|
Shinsuke, Nanto, M.D.
(Osaka University Graduate School of Medicine) |
|
|
Co-sponsored by DVx Inc.
|
|
|
|
|
